E
Galmed Pharmaceuticals Ltd. GLMD
$1.56 $0.000.28% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 06/30/2024 06/30/2024
Net Income -122.97% 13.41% -59.18% 29.76% 29.76%
Total Depreciation and Amortization -- -- -100.00% 722.22% 722.22%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 399.17% -49.35% 1,435.29% 700.00% 700.00%
Change in Net Operating Assets 782.61% 80.36% -159.11% -145.54% -145.54%
Cash from Operations -24.68% 36.23% -119.27% 25.60% 25.60%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -428.23% -153.47% -255.73% 97.45% 97.45%
Cash from Investing -428.23% -153.47% -255.73% 97.45% 97.45%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -47.20% 108.30% -467.13% 156.65% 156.65%